Washington: Anthony Fawcett, the country’s top infectious disease specialist, says the US booster shot campaign against Kovid-1 is likely to start on September 20 with the Pfizer vaccine only. Although both drug manufacturers have applied to the US Food and Drug Administration (FDA) for a third dose approval six months or eight months after receiving the second dose, they have not been formally approved by the agency.
While awaiting approval, the Joe Biden administration has announced that Pfizer and Moderena shots will be given a third dose.
Only the Pfizer vaccine booster can get FDA and Centers for Disease Control and Prevention (CDC) approval, Fawcett told CBS’s “Faces the Nation.”
Pfizer, which has the data, is likely to meet the deadline, the director of the National Institute of Allergy and Infectious Diseases told CBS. We hope Moderena will be able to do the same, so we can do it together.
But if that doesn’t happen, we’ll do it sequentially, he continued. Ikkato Bottom Line, most likely, at least part of the plan will be implemented, but in the end the whole plan.
CNN reported that he was not in favor of mixing the doses. And for those who have received two doses of the modern vaccine, it is better to wait for the third dose of Modern than to take a Pfizer shot.
Booster doses of Pfizer and Moderner doses are based on CDC data showing protection against infection a few months after the second shot.
The report said the FDA advisory panel will review Pfizer’s application for the booster on Sept. 17.
According to the CDC, more than 1.3 million immunocompromised individuals received additional shots.